M.A. Mont, L.C. Jones, J.M. Smith, D.R. Marker, S.D. Ulrich1, and D.S. Hungerford
Rubin Institute for Advanced Orthopedics, Center for Joint Preservation and Reconstruction, Sinai Hospital of Baltimore, Baltimore, Maryland USA
The Johns Hopkins University Department of Orthopaedics at the Good Samaritan Hospital, Baltimore, Maryland USA
Introduction: Historically, bone scintigraphy has been advocated as a useful diagnostic tool for patients with suspected osteonecrosis or in screening for multifocal disease. The principle aim of this study was to evaluate the sensitivity of bone scanning relative to magnetic resonance imaging in the diagnosis of osteonecrosis.
Methods: Forty-eight patients presented with suspected osteonecrosis of the shoulder, hip, knee, or ankle. All patients underwent simultaneous (less than three months apart) bone scans and magnetic resonance imaging studies as part of a diagnostic work-up. Histological confirmation of osteonecrosis was obtained for all suspected lesions in the study. The diagnostic yield for each imaging modality was then assessed and compared.
Results: All one hundred sixty-three (100%) histologically confirmed lesions were identified by magnetic resonance imaging, while only ninety-one lesions (56%) were identified by bone scan. There was complete uniformity of bone scans with magnetic resonance images in only 38% of patients (eighteen of forty-eight). Bone scanning identified 72% of lesions (forty-seven of sixty-five) in oligofocal patients (less than two involved joints) compared with 45% of the lesions (forty-four of ninety-eight) in multifocal patients (more than two joints involved). Sensitivity of the lesions was highest for the knee and hip and lower for the shoulder and ankle. Larger and later stage lesions had higher bone scan sensitivity.
Conclusions: The results of this study have demonstrated the low sensitivity of bone scintigraphy for diagnosing symptomatic osteonecrosis. Bone scanning did not detect 44% of the lesions (seventy-two of one hundred sixty-three). This study does not support the use of bone scans as a diagnostic or screening tool for this disease.